Automation & robotics

Robotic and software platforms that automate the closed, GMP-grade cell culture and manufacturing steps behind cell and gene therapies — end-to-end automated manufacturing platforms, robotic drug-product handling, and the scheduling/orchestration software coordinating multi-instrument automated workflows — sold by four specialists (Cellares, Multiply Labs, Ori Biotech, HighRes Biosolutions) targeting the labor-intensive, variability-prone manual cell-therapy manufacturing process.

Multi-tenant, remotely operated wet labs that execute user-submitted protocols via API and return structured data — the layer that turns biology into programmable infrastructure, decoupling experiment design from bench work and feeding the closed-loop AI-driven autonomous lab.

Robotic platforms that image a microbial plate, score colonies by size, morphology and fluorescence, then pick and re-array 200–3,000 colonies an hour into fresh growth plates — the automated front end of strain engineering, directed evolution, CRISPR clone screening and microbiome culturomics.

Overhead gantry and robotic-arm hardware that physically transports microplates and labware between instruments in an automated wet-lab workflow — the plate-movement layer distinct from the liquid-handling and colony-picking instruments it feeds — sold by four specialists (HighRes Biosolutions, Thermo Fisher, Peak Analysis and Automation, Agilent) spanning integrated automation-system builders through single-instrument microplate movers.

High-throughput robotic liquid handling systems and integrated laboratory automation platforms that exponentially increase assay throughput, eliminate human error, and enable next-generation genomics and synthetic biology.

High-throughput robotic systems and liquid handling workstations driving autonomous, reproducible bio-research and screening.

Industrial automation software orchestrating complex bioreactor operations and enforcing regulatory compliance through electronic batch records.

Public-private manufacturing-innovation institutes that operate shared pilot- and demonstration-scale biomanufacturing facilities, letting a biologic developer run small-batch production and prove out a process before committing capital to a dedicated commercial-scale plant.

A genuinely thin, single-vendor automation category — fully automated, unattended seed-train expansion for adherent cell culture — distinct from the broader wave/single-use bioreactor hardware market already covered on this site.